# BioActs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioacts

- Industry: Materials
- Headquarters: Incheon, South Korea
- Website: www.bioacts.com
- Total disclosed funding: $3.1M
- Latest round: Series B (Jul 1, 2017)
- Investors on record: 3

## About

Established in 1976 and based in South Korea, BioActs is a research and development company that focuses on the development of fluorescent materials and optical contrast agents. In 2005, the company started producing antibacterial dyes and blue fluorescent OLED material. In 2009, the company established the biological division. In 2016, the company changed its name to BioActs. Jong Joo Na, the CEO of the company, was the CEO of DKC Corporation.

The company's main products include fluorescent dyes, optical contrast agent, fluorescent antibodies, magnetic beads, and dye labeling kit, etc. Optical contrast agents are used in animal model studies. The company's products are used in the fields of biomedicine and pharmaceuticals.

## Funding rounds

- Series B, Jul 1, 2017, $3.1M — G.N.TECH Venture Capital, DT&Investment, Sejong Venture Partners

## Investors

- G.N.TECH Venture Capital (https://capitalatlas.ai/funds/g-n-tech-venture-capital) — Series B
- DT&Investment (https://capitalatlas.ai/funds/dt-investment) — Series B
- Sejong Venture Partners — Series B